CKD 1 5T notation applies to kidney transplant recipients. a 5D if dialysis (HD or PD). STAGES OF CHRONIC KIDNEY DISEASE Kidney International Supplements (2012) 2, vii vii http://www.kidney-international.org & 2012 KDIGO Kidney International Supplements (2012) 2, viii viii Abbreviations and Acronyms AASK African American Study of Kidney Disease and Hypertension ABCD Appropriate Blood Pressure Control in Diabetes ABPM Ambulatory blood pressure monitoring ACCF American College of Cardiology Foundation ACCORD Action to Control Cardiovascular Risk in Diabetes ACE-I Angiotensin-converting enzyme inhibitor ACR Albumin/creatinine ratio ADVANCE Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation AER Albumin excretion rate AGREE Appraisal of Guidelines for Research and Evaluation AHA American Heart Association ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALTITUDE Aliskiren Trial in Type 2 Diabetes Using Cardio- vascular and Renal Disease Endpoints ARB Angiotensin-receptor blocker BMI Body mass index BP Blood pressure CAD Coronary artery disease CASE J Candesartan Antihypertensive Survival Evaluation in Japan CI Confidence interval CKD Chronic kidney disease CKD-EPI CKD Epidemiology Collaboration CKD ND Non dialysis-dependent CKD of any stage CKD T Non dialysis-dependent CKD of any stage with a kidney transplant CKD 5D Dialysis-dependent CKD 5 CKiD Chronic Kidney Disease in Children CNI Calcineurin inhibitor COGS Conference on Guideline Standardization CPG Clinical practice guideline CRIC Chronic Renal Insufficiency Cohort CVD Cardiovascular disease DCCT/EDIC Diabetes Control and Complications Trial/Epide- miology of Diabetes Interventions and Complications DRI Direct renin inhibitor EDC Pittsburgh Epidemiology of Diabetes Complica- tions Study ERT Evidence review team ESCAPE Effect of Strict Blood Pressure Control and ACE- Inhibition on Progression of Chronic Renal Failure in Pediatric Patients EUROPA European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease FDA Food and Drug Administration GFR Glomerular filtration rate GRADE Grading of Recommendations Assessment, Development and Evaluation HOPE Heart Outcomes Prevention Evaluation HOT Hypertension Optimal Treatment HR Hazard ratio HYVET Hypertension in the Very Elderly Trial ICD International Classification of Diseases IDNT Irbesartan Diabetic Nephropathy Trial INVEST International Verapamil SR Trandolapril study JATOS Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients JNC Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure KDIGO Kidney Disease: Improving Global Outcomes KDOQI Kidney Disease Outcomes Quality Initiative KEEP Kidney Early Evaluation Program MAP Mean arterial pressure MDRD Modification of Diet in Renal Disease MRFIT Multiple Risk Factor Intervention trial mTOR Mammalian target of rapamycin NHANES National Health and Nutrition Examination Survey NICE National Institute for Health and Clinical Excellence NIH National Institutes of Health NKF National Kidney Foundation NSAID Nonsteroidal anti-inflammatory drug ONTARGET Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint trial PCR Protein/creatinine ratio PEACE Prevention of Events with Angiotensin-Convert- ing Enzyme Inhibitor Therapy PREVEND IT Prevention of Renal and Vascular Endstage Disease Intervention Trial PROGRESS Perindopril Protection Against Recurrent Stroke Study RAAS Renin-angiotensin-aldosterone system RCT Randomized controlled trial REIN-2 Ramipril Efficacy in Nephropathy 2 RENAAL Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan RR Relative risk SCr Serum creatinine SD Standard deviation SECRET Study on Evaluation of Candesartan Cilexetil after Renal Transplantation SHEP Systolic Hypertension in the Elderly Program SPRINT Systolic Blood Pressure Intervention Trial Steno-2 Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria STONE Shanghai Trial of Nifedipine in the Elderly Syst-Eur Systolic Hypertension in Europe TRANSCEND Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease UKPDS United Kingdom Prospective Diabetes Study VALISH Valsartan in Elderly Isolated Systolic Hypertension WHO World Health Organization http://www.kidney-international.org & 2012 KDIGO Notice SECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE This Clinical Practice Guideline document is based upon systematic literature searches last conducted in January 2011, supplemented with additional evidence through February 2012. 